Comprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancer

被引：3
作者：
Lissa, Delphine [1 ]
Robles, Ana I. [2 ]
机构：
[1] NCI, Lab Human Carcinogenesis, NIH, Bethesda, MD 20892 USA
[2] NCI, Off Canc Clin Prote Res, NIH, Bethesda, MD 20892 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 05期
关键词：
D O I：
10.21037/atm.2018.12.57
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[41]   Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer [J].
Marinello, Arianna ;
Tagliamento, Marco ;
Pagliaro, Arianna ;
Conci, Nicole ;
Cella, Eugenia ;
Vasseur, Damien ;
Remon, Jordi ;
Levy, Antonin ;
Dall'Olio, Filippo Gustavo ;
Besse, Benjamin .
CANCER TREATMENT REVIEWS, 2024, 129
[42]   Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer [J].
Xu, Ruilian ;
Zhong, Guolin ;
Huang, Tanxiao ;
He, Wan ;
Kong, Cheng ;
Zhang, Xiaoni ;
Wang, Ying ;
Liu, Ming ;
Xu, Mingyan ;
Chen, Shifu .
ONCOLOGY LETTERS, 2018, 15 (03) :3726-3734
[43]   Circulating Tumor Cell as a Predictive Marker for Immunotherapy in Advanced Non-Small Cell Lung Cancer [J].
Park, C. ;
Oh, H. ;
Kim, M. ;
Kim, B. ;
Cho, H. ;
Oh, I. ;
Kim, Y. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S418-S418
[44]   Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA [J].
Goldberg, S. B. ;
Narayan, A. ;
Kole, A. J. ;
Decker, R. H. ;
Teysir, J. ;
Carriero, N. J. ;
Lee, A. ;
Nemati, R. ;
Nath, S. K. ;
Mane, S. M. ;
Deng, Y. ;
Sukumar, N. ;
Zelterman, D. ;
Boffa, D. J. ;
Politi, K. ;
Gettinger, S. N. ;
Wilson, L. D. ;
Herbst, R. S. ;
Patel, A. A. .
ANNALS OF ONCOLOGY, 2017, 28
[45]   The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC) [J].
Grinberg, R. ;
Roisman, L. C. ;
Geva, S. ;
Soussan-Gutman, L. ;
Dvir, A. ;
Yair, R. ;
Twito, T. ;
Larman, R. ;
Peled, N. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) :S35-S36
[46]   The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) [J].
Grinberg, R. ;
Roisman, L. ;
Geva, S. ;
Lefterova, M. ;
Quinn, K. ;
Gutman, L. Soussan ;
Dvir, A. ;
Yair, R. ;
Twito, T. ;
Lanman, R. ;
Peled, N. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S925-S926
[47]   Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer [J].
Pellini, Bruna ;
Szymanski, Jeffrey ;
Chin, Re-, I ;
Jones, Paul A. ;
Chaudhuri, Aadel A. .
THORACIC SURGERY CLINICS, 2020, 30 (02) :165-+
[48]   Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer [J].
Peng, Muyun ;
Huang, Qi ;
Yin, Wei ;
Tan, Sichuang ;
Chen, Chen ;
Liu, Wenliang ;
Tang, Jingqun ;
Wang, Xiang ;
Zhang, Bingyu ;
Zou, Min ;
Li, Jina ;
Su, Wenhui ;
Wang, Lientu ;
Chin, Lihan ;
Yu, Fenglei .
FRONTIERS IN ONCOLOGY, 2020, 10
[49]   The expanding role of circulating tumor DNA in resectable non-small cell lung cancer [J].
Morgensztern, Daniel .
CANCER, 2024, 130 (10) :1730-1732
[50]   Comprehensive analysis of blood-based biomarkers to immunotherapy using circulating tumor cells, peripheral blood cells and circulating tumor DNA in advanced non-small cell lung cancer. [J].
Park, Cheol-Kyu ;
Cho, Hyun-Ju ;
Oh, In-Jae ;
Kim, Young-Chul .
CANCER RESEARCH, 2021, 81 (13)
12345